TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Leishmaniasis
Reports on leishmaniasis findings from S. Farajnia and co-researchers provide new insights
December 2nd, 2008
"The purpose of this study was to prepare recombinant K26 antigen from Leishmania infantum and evaluate its performance by enzyme-linked immunosorbent assay (ELISA) test for serodiagnosis of visceral leishmaniasis (VL) in endemic regions of Iran. The results were compared with those obtained by direct agglutination test (DAT) and whole cell ELISA using crude parasite antigen," scientists in Iran report. "Of 93 sera from patients with confirmed NIL, 90 sera were positive with rK26 ELISA (sensitivity = 96.8%), whereas 85 sera were positive with DAT (sensitivity = 91.4%) and 89 sera were positive with whole cell E I., I SA (sensitivity = 95.7%). Of 130 subjects who either...
Source: TB & Outbreaks Week (2008-12-02)
|
